{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:35:50Z","timestamp":1791920150350,"version":"4.3.4"},"reference-count":50,"publisher":"Informa UK Limited","issue":"5","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Cardiol."],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.2217\/fca-2019-0089","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T09:16:52Z","timestamp":1587547012000},"page":"505-515","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":29,"title":["ARNI in Cardiovascular Disease: Current Evidence and Future Perspectives"],"prefix":"10.1080","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5852-0752","authenticated-orcid":false,"given":"Pramod Kumar","family":"Kuchulakanti","sequence":"first","affiliation":[{"name":"Department of Cardiology Yashoda Hospitals Somajiguda Hyderabad\rTelangana\rIndia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2020,4,22]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(81)90370-2"},{"key":"e_1_3_2_4_1","first-page":"557","article-title":"Innovative therapeutics-designer natriuretic peptides","volume":"7","author":"Meems MG L","year":"2016","unstructured":"Meems MG L , BurnettJCJr. Innovative therapeutics-designer natriuretic peptides. J. Am. Coll. Cardiol., 7, 557\u2013567 (2016).","journal-title":"J. Am. Coll. Cardiol."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/1071-9164(95)90007-1"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2012.00093"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02602-7"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000029801.86489.50"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2014-306775"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjhyper.2003.09.014"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hft052"},{"issue":"1","key":"e_1_3_2_12_1","first-page":"S1","article-title":"The use of sacubitril\/valsartan (LCZ696) in clinical practice","volume":"23","author":"McMurray J","year":"2016","unstructured":"McMurray J . The use of sacubitril\/valsartan (LCZ696) in clinical practice. Br. J. Cardiol., 23(Suppl. 1), S1\u2013S16 (2016).","journal-title":"Br. J. Cardiol."},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.592"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehq426"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1409077"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.114.013748"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000509"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1812851"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.1498"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61227-6"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14285-7"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908655"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMe1912402"},{"key":"e_1_3_2_24_1","unstructured":"Novartis . A randomized double-blind controlled study comparing LCZ696 to medical therapy for comorbidities in HFpEF patients (PARALLAX).2019). https:\/\/clinicaltrials.gov>show>NCT03066804"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.163.10.1155"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.117.026112"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2017.02.034"},{"key":"e_1_3_2_28_1","unstructured":"Novartis . Prospective ARNI vs ACE inhibitor trial to determine superiority in reducing heart failure events after MI (PARADISE-MI). (2019). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02924727"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(99)00630-0"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.12821"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1111\/1755-5922.12435"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.037077"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv186"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2017.11.012"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30087-6"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(09)61966-8"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02002"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv142"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.116.08556"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehw570"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2005.00365.x"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.034818"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jjcc.2019.03.010"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jccase.2019.08.006"},{"issue":"1","key":"e_1_3_2_45_1","first-page":"11834","article-title":"Early reduction in elevated pulmonary artery pressures after initiation of sacubitril\/valsartan: insights from ambulatory hemodynamic monitoring","volume":"140","author":"Desai A","year":"2019","unstructured":"Desai A , HeywoodJT, RathmanLet al. Early reduction in elevated pulmonary artery pressures after initiation of sacubitril\/valsartan: insights from ambulatory hemodynamic monitoring. Circulation, 140(Suppl.1), 11834 (2019).","journal-title":"Circulation"},{"key":"e_1_3_2_46_1","unstructured":"Novartis . Pulmonary Artery Pressure Reduction With ENTresto (Sacubitril\/Valsartan) (PARENT). clinicaltrials.gov\/ct2\/show\/NCT02788656. ClinicalTrials.gov Identifier: NCT02788656."},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0735-1097(17)34123-2"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2016.200"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.687"},{"key":"e_1_3_2_50_1","unstructured":"Novartis . Efficacy and safety of LCZ696 compared to valsartan on cognitive function in patients with chronic heart failure and preserved ejection fraction (PERSPECTIVE). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02884206. ClinicalTrials.gov Identifier: NCT02884206."},{"key":"e_1_3_2_51_1","unstructured":"Novartis . Sacubitril-valsartan and heart failure patients: the ENTRESTO-SAS study. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02916160. ClinicalTrials.gov Identifier: NCT02916160."},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/13543784.2019.1551357"}],"container-title":["Future Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fca-2019-0089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T17:38:44Z","timestamp":1715967524000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fca-2019-0089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,22]]},"references-count":50,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.2217\/fca-2019-0089"],"URL":"https:\/\/doi.org\/10.2217\/fca-2019-0089","relation":{},"ISSN":["1479-6678","1744-8298"],"issn-type":[{"value":"1479-6678","type":"print"},{"value":"1744-8298","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,22]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifca20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifca20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2019-12-12","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-03-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-04-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}